Ad
SOLTF Short Information Nxera Pharma Co Ltd Ord
home / stock / soltf / soltf short
Short Information | Nxera Pharma Co Ltd Ord (OTCMKTS:SOLTF)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 37,176 |
| Total Actual Volume | 63,081 |
| Short Trends | |
|---|---|
| Cover Days | 5 |
| Short Days | 14 |
| No Change Days | 1 |
| Averages | |
|---|---|
| Average Short Volume | 1,859 |
| Average Short Percentage | 74.64% |
Is there a SOLTF Short Squeeze or Breakout about to happen?
See the SOLTF Short Analysis for free Sign up or Login
Powered by Squeeze Report
SOLTF Twenty Trading Day's Volume to Short Volume Chart
SOLTF Twenty Trading Day Price Chart
SOLTF Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 11-04-2024 | $7.75 | $7.75 | $7.75 | $7.75 | 110 | 110 | 100% |
| 10-17-2024 | $7 | $7.132 | $7.132 | $7 | 2,400 | 1,000 | 41.67% |
| 10-01-2024 | $8.98 | $9.02 | $9.02 | $8.98 | 300 | 300 | 100% |
| 08-28-2024 | $10.62 | $10.62 | $10.62 | $10.62 | 200 | 200 | 100% |
| 08-15-2024 | $9.46 | $9.46 | $9.46 | $9.46 | 100 | 100 | 100% |
| 08-01-2024 | $9.96 | $10.15 | $10.15 | $9.96 | 500 | 500 | 100% |
| 05-13-2024 | $9.67 | $9.8 | $9.8 | $9.67 | 1,000 | 900 | 90% |
| 05-10-2024 | $9.816 | $9.816 | $9.816 | $9.816 | 1 | 1 | 100% |
| 04-16-2024 | $9.72 | $9.72 | $9.72 | $9.72 | 100 | 100 | 100% |
| 04-08-2024 | $10.44 | $10.44 | $10.44 | $10.44 | 300 | 300 | 100% |
| 03-13-2024 | $10.7461 | $10.7461 | $10.7461 | $10.7461 | 465 | 465 | 100% |
| 03-11-2024 | $11.88 | $13.43 | $13.43 | $11.71 | 50,102 | 30,500 | 60.88% |
| 02-15-2024 | $8.56 | $8.65 | $8.715 | $8.56 | 1,500 | 100 | 6.67% |
| 02-14-2024 | $9.5 | $9.5 | $9.5 | $9.5 | 500 | 500 | 100% |
| 01-29-2024 | $9.81 | $9.822 | $9.822 | $9.75 | 300 | 100 | 33.33% |
| 01-10-2024 | $10.5 | $10.89 | $10.89 | $10.5 | 2,303 | 200 | 8.68% |
| 12-15-2023 | $10.2 | $9.95 | $10.2 | $9.95 | 300 | 100 | 33.33% |
| 12-14-2023 | $10.17 | $10.17 | $10.17 | $10.17 | 1,000 | 1,000 | 100% |
| 12-04-2023 | $9.708 | $9.48 | $9.708 | $9.48 | 1,100 | 200 | 18.18% |
| 11-22-2023 | $10 | $10 | $10 | $10 | 500 | 500 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Nxera Pharma Co Ltd Ord Company Name:
SOLTF Stock Symbol:
OTCMKTS Market:
100.0% G/L:
$6.52 Last:
1,300 Volume:
$0 Open:
$6.52 Close:
Ad
-
Daridorexant is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as insomnia Filing of daridorexant in Taiwan planned for 2025, and launch, if approved, is expected during 2026 Daridorexant is launched in Japa...
-
Cenerimod is a novel oral S1P 1 receptor modulator with potential to be a first- or best-in-class therapy for multiple autoimmune diseases Viatris previously acquired rights to cenerimod in all other territories from Idorsia, and now has exclusive global rights Nxera will receive an u...
-
Tokyo, Japan and Cambridge, UK, 14 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the fourth quarter and 12 months ended 31 December 2024...
Important Investor News Alert (OTC: AVAI)
-
LAS VEGAS, NV / ACCESS Newswire / March 10, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), tod...